CD274 and adenocarcinoma: On univariate analysis, the tumors of patients with adenocarcinoma or driver mutation‐positive were more likely to have no PD‐L1 expression compared to those with non‐adenocarcinoma histology or driver mutation‐negative (Tables 2 and 3).